Non-specific effects of vaccines: plausible and potentially important, but implications uncertain
Andrew J Pollard, Adam Finn, Nigel Curtis
Archives of Disease in Childhood | BMJ PUBLISHING GROUP | Published : 2017
AJP leads academic trials or publicly funded research on vaccines. A grant to Oxford University from Okairos to study respiratory syncytial vaccines ended in 2016. His department received unrestricted educational grants from Pfizer/GSK/AstraZeneca in July 2016 for a course on Infection and Immunity in Children. Other investigators in the Department conduct research funded by vaccine manufacturers. AJP chairs the UK Department of Health's Joint Committee on Vaccination an Immunisation and the scientific advisory group on vaccines for the European Medicines Agency and is a member of the WHO's SAGE. He previously contributed to the WHO systematic review on non-specific immunological effects of vaccines. AF undertakes research studies and trials of vaccines funded by governments, charities and industry. He is a member of the UK Department of Health's Joint Committee on Vaccination, Chair of the WHO European Technical Advisory Group of Experts in which capacity he attends SAGE and President of the European Society for Paediatric Infectious Diseases, which receives sponsorship for its annual meeting from vaccine manufacturers. NC is leading a large randomised controlled trial (RCT) of BCG in infants (ClinicalTrials. gov identifier NCT01906853). He is a member of the WHO SAGE Working Group on BCG vaccines. He is a board member of the European Society for Paediatric Infectious Diseases, which receives sponsorship for its annual meeting from vaccine manufacturers.